Ofloxacino Pos Brill Pharma

Ofloxacin, the active ingredient in Ofloxacino Pos Brill Pharma, is a fluoroquinolone antibiotic presented as a strength/form for oral use. It treats bacterial infections in adults and children when indicated. GNH USA supplies Ofloxacino Pos Brill Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ofloxacino Pos Brill Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacin is a broad‑spectrum fluoroquinolone used to treat infections caused by susceptible bacteria in several organ systems.

- Eye infections: helps eradicate bacterial conjunctivitis and keratitis. - Respiratory tract infections: aids in the treatment of acute exacerbations of chronic bronchitis and community‑acquired pneumonia. - Urinary tract infections: eliminates pathogens responsible for uncomplicated cystitis and pyelonephritis. - Skin and soft‑tissue infections: assists in clearing bacterial cellulitis and wound infections. - Sexually transmitted infections: used for uncomplicated gonorrhoea caused by susceptible strains.

Ofloxacin may cause a range of adverse reactions, from mild to severe, depending on individual susceptibility and treatment duration.

Common Side Effects: - Nausea: mild stomach upset often reported. - Diarrhea: loose stools occurring during therapy. - Headache: transient head pain without neurological signs. - Dizziness: occasional light‑headed sensation. - Skin rash: mild erythema or itching. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or rupture, especially in the Achilles. - QT prolongation: cardiac rhythm changes that may lead to arrhythmia. - Severe allergic reaction: anaphylaxis, angioedema or bronchospasm. - Peripheral neuropathy: tingling, numbness or weakness in extremities. - Hepatotoxicity: elevated liver enzymes or jaundice. - Central nervous system effects: seizures or psychosis.

When using Ofloxacin, clinicians should assess patient history and monitor for specific safety concerns.

- Renal impairment: adjust dose in patients with reduced kidney function. - Hepatic disease: use with caution in liver dysfunction. - Pregnancy and lactation: avoid unless clearly needed, as risks to the fetus or infant are not fully known. - Concomitant QT‑prolonging drugs: monitor cardiac rhythm when combined with other agents that affect QT interval. - Tendon disorders: advise patients to report tendon pain, especially if engaged in vigorous activity. - Age considerations: use cautiously in the elderly due to higher risk of adverse events. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ofloxacin can interact with several medicines, altering its effectiveness or increasing toxicity risk.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of Ofloxacin. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: heightened risk of neurotoxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of central nervous system stimulation. - Theophylline: potential for increased serum concentrations. - Corticosteroids: may raise the chance of tendon rupture. - Diabetic agents: possible alteration of blood glucose control.